batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Halozyme abandons Evotec proposal 25 November 2024 ASH 2024 preview – Incyte gets a Monjuvi coup 25 November 2024 Perspective's lead balloon 21 November 2024 Jefferies 2024 – Nuvation lays out its US taletrectinib strategy 19 November 2024 Amgen pushes on in Steap1 19 November 2024 Merck finally gets under the skin with Keytruda 19 November 2024 Jefferies 2024 – Arvinas gets a degrader delay 19 November 2024 Avenzo's second trip to China 18 November 2024 Load More